n-methyl-n-formylhydrazine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-methyl-N-formylhydrazine: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID Source	ID
PubMed CID	12962
MeSH ID	M0066675

Synonyms (36)

Synonym
unii-3l13r06h7d
3l13r06h7d ,
hydrazine, 1-formyl-1-methyl-
nsc122452
nsc-122452
1-methylformylhydrazine
formic acid, 1-methylhydrazide
758-17-8
methylformylhydrazine
1-methyl-1-formylhydrazide
n-formyl-n-methylhydrazine
formic acid, methylhydrazide
2-methyl-2-formylhydrazine
hydrazinecarboxaldehyde, 1-methyl-
n-methyl-n-formylhydrazine
n-methylformic hydrazide
hsdb 3510
nsc 122452
brn 2036827
MFH ,
1-methyl-1-formylhydrazine
ccris 1182
n-amino-n-methylformamide
AKOS006279317
n-methyl-n-formylhydrazine [hsdb]
1-formyl-1-methylhydrazine
1-methylhydrazinecarboxaldehyde
CCG-214845
RSFOTOSOKJMMCB-UHFFFAOYSA-N
DTXSID2020840
CS-0084846
n-methylformohydrazide
D74578
Q27257474
SY338851
mfcd01726298

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	8 (88.89)	18.7374
1990's	1 (11.11)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.79

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

Metric	This Compound (vs All)
Research Demand Index	11.79 (24.57)
Research Supply Index	2.48 (2.92)
Research Growth Index	4.28 (4.65)
Search Engine Demand Index	0.00 (26.88)
Search Engine Supply Index	0.00 (0.95)

This Compound (11.79)

All Compounds (24.57)

Study Types

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	11 (100.00%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Classes	Roles
acetaldehyde Acetaldehyde: A colorless, flammable liquid used in the manufacture of acetic acid, perfumes, and flavors. It is also an intermediate in the metabolism of alcohol. It has a general narcotic action and also causes irritation of mucous membranes. Large doses may cause death from respiratory paralysis.. acetaldehyde : The aldehyde formed from acetic acid by reduction of the carboxy group. It is the most abundant carcinogen in tobacco smoke.. aldehyde : A compound RC(=O)H, in which a carbonyl group is bonded to one hydrogen atom and to one R group.. acetyl group : A group, formally derived from acetic acid by dehydroxylation, which is fundamental to the biochemistry of all forms of life. When bound to coenzyme A, it is central to the metabolism of carbohydrates and fats.	2.37	2	aldehyde	carcinogenic agent; EC 3.5.1.4 (amidase) inhibitor; electron acceptor; Escherichia coli metabolite; human metabolite; mouse metabolite; mutagen; oxidising agent; Saccharomyces cerevisiae metabolite; teratogenic agent
formaldehyde paraform: polymerized formaldehyde; RN given refers to parent cpd; used in root canal therapy	1.97	1	aldehyde; one-carbon compound	allergen; carcinogenic agent; disinfectant; EC 3.5.1.4 (amidase) inhibitor; environmental contaminant; Escherichia coli metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
hexobarbital Hexobarbital: A barbiturate that is effective as a hypnotic and sedative.. hexobarbital : A member of the class of barbiturates taht is barbituric acid substituted at N-1 by methyl and at C-5 by methyl and cyclohex-1-enyl groups.	1.95	1	barbiturates
aminopyrine Aminopyrine: A pyrazolone with analgesic, anti-inflammatory, and antipyretic properties but has risk of AGRANULOCYTOSIS. A breath test with 13C-labeled aminopyrine has been used as a non-invasive measure of CYTOCHROME P-450 metabolic activity in LIVER FUNCTION TESTS.. aminophenazone : A pyrazolone that is 1,2-dihydro-3H-pyrazol-3-one substituted by a dimethylamino group at position 4, methyl groups at positions 1 and 5 and a phenyl group at position 2. It exhibits analgesic, anti-inflammatory, and antipyretic properties.	1.95	1	pyrazolone; tertiary amino compound	antipyretic; environmental contaminant; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic
monomethylhydrazine Monomethylhydrazine: Hydrazine substituted by one methyl group.	3.57	9
diazene [no description available]	1.97	1	nitrogen hydride
gyromitrin gyromitrin: isolated from edible mushroom Gyromitra (Helvella) esculenta; inhalation hallucinogen; highly toxic; structure	1.95	1

Condition	Relationship Strength	Studies
Cancer of Lung [description not available]	3.05	5
Experimental Neoplasms [description not available]	3.05	5
Lung Neoplasms Tumors or cancer of the LUNG.	3.05	5
Cancer of Gallbladder [description not available]	2.87	4
Cancer of Liver [description not available]	2.65	3
Gallbladder Neoplasms Tumors or cancer of the gallbladder.	2.87	4
Liver Neoplasms Tumors or cancer of the LIVER.	2.65	3
Adenocarcinoma, Basal Cell [description not available]	1.96	1
Adenoma, Basal Cell [description not available]	1.96	1
Benign Neoplasms [description not available]	1.96	1
Adenocarcinoma A malignant epithelial tumor with a glandular organization.	1.96	1
Adenoma A benign epithelial tumor with a glandular organization.	1.96	1
Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.	1.96	1
Bile Duct Cancer [description not available]	2.36	2
Experimental Hepatoma [description not available]	1.95	1
Angioma, Sclerosing [description not available]	1.95	1
Bile Duct Neoplasms Tumors or cancer of the BILE DUCTS.	2.36	2
Histiocytoma, Benign Fibrous A benign tumor composed, wholly or in part, of cells with the morphologic characteristics of HISTIOCYTES and with various fibroblastic components. Fibrous histiocytomas can occur anywhere in the body. When they occur in the skin, they are called dermatofibromas or sclerosing hemangiomas. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 5th ed, p1747)	1.95	1
Acute Liver Injury, Drug-Induced [description not available]	1.95	1
Mushroom Poisoning Poisoning from ingestion of mushrooms, primarily from, but not restricted to, toxic varieties.	2.36	2
Chemical and Drug Induced Liver Injury A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment.	1.95	1
Angioma A vascular anomaly due to proliferation of blood or lymphatic vessels that forms a tumor-like mass. Vessels in the angioma may or may not be dilated.	1.95	1
Angiosarcoma [description not available]	1.95	1
Hemangioma A vascular anomaly due to proliferation of BLOOD VESSELS that forms a tumor-like mass. The common types involve CAPILLARIES and VEINS. It can occur anywhere in the body but is most frequently noticed in the SKIN and SUBCUTANEOUS TISSUE. (from Stedman, 27th ed, 2000)	1.95	1
Hemangiosarcoma A rare malignant neoplasm characterized by rapidly proliferating, extensively infiltrating, anaplastic cells derived from blood vessels and lining irregular blood-filled or lumpy spaces. (Stedman, 25th ed)	1.95	1

chemdatabank.com